Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

NCT02555683 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

894

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: QAW039
DRUG: QAW039
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals